() gained 2.5% in midday trading on Friday. The company traded up to $1.63, and traded last at $1.63. The volume of shares traded at midday was down 85% compared to the average session of 131,151. Stock had closed previously at $1.59.
DiaMedica Therapeutics Price Performance
The company has a simple moving-average of $1.67 for the past 50 days and $1.49 for the last 200 days.
DiaMedica Therapeutics Company profile
DiaMedica Therapeutics Inc is a biopharmaceutical firm in clinical stages that develops treatments for neurological diseases and kidney disease. The company's leading product, DM199, is a recombinant kallikrein-1 human tissue protein that is currently in Phase II clinical studies for acute ischemicstroke and kidney injury indications.
MarketBeat.com offers a FREE daily email newsletter